Skip to content

Evaluation of the Active Warming Effects on Maternal and Neonatal Outcome During Cesarean Delivery

Evaluation of the Active Warming Effects on Maternal and Neonatal Outcomes During Cesarean Delivery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03473470
Enrollment
165
Registered
2018-03-22
Start date
2016-12-22
Completion date
2020-11-30
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia; Anesthesia

Keywords

Maternal and Neonatal Hypothermia, cesarean delivery

Brief summary

A prospective randomized study of healthy term parturients undergoing cesarean delivery was designed to assess the impact of the active warming on perioperative and postoperative temperature. The main objective is to evaluate the maternal core temperature in the perioperative and postoperative period during cesarean delivery. The secondary objectives are to assess the incidence of maternal hypothermia, the incidence of maternal shivers, the evaluation of maternal thermal comfort, the neonatal temperature at birth, the Apgar score at 1 and 5 minutes, the umbilical pH, the evaluation of coagulative assessment in case of maternal hypothermia trough the use of thromboelastography. The patients are randomized into three groups: a group of no warmed patients, a second group of Active waming patients with iv fluids and lower body forced air warming and a third group of Active warming patients with only warmed iv fluids. The inclusion criteria are healthy parturients up to age 18. The exclusion criteria included parturients who develop fever, diabetes mellitus, BMI up to 40kg/ m2, coagulative disorders, pre eclampsia or eclampsia, all the factors that can cause intraoperative bleeding such as placental abruption or antecedent placenta overgrowth ( placenta previa).

Detailed description

The doctor's main purposes during the perioperative period are the monitorign and maintenance of normothermia, as well as the haemodynamic, respiratory, metabolic, analgesic control and monitoring. Mild hypothermia ( core temperature between 36° and 33° C) is common during general, locoregional or blended anaesthesia. A mild hypothermia can cause a cardiovascular, haematological, metaolic and hormonal alterations that can explain an increased mortality and morbidity in hypothermia patients versus normothermia patients. Thermic decrease is a physiological event during general or locoregional anaesthesia. Particularly spinal and epidural anaesthesia can cause the thermic decrease because of vasodilation below the level of the sensitive and neuroaxial blockade. In this way there is in the patient an increased heat loss trough radiation. The neuroaxial techniques can reduce the sensory connections and the level of vasoconstriction above the level of the sensorial blockade, reducing the patient capacity to maintain the poichilothermia. The consequences of hypothermia are important because they can influence the intraoperative management causing complications extending the recovering time and the hospitalization. The environmental temperature is a critical factor for the development of hypothermia , especially in critically patients. In order to avoid the deveopment of hypothermia the environmental temperature must be maintainde between 21° and 24° C and humidity level of 40- 60%. Maternal hypothermia is common during cesarean delivery and it can exercise influence over neonatal temperature. When a mother develops hypothermia the newborn can shows hypotheria, umbilical acidosis, low Apgar score at birth. The recorded data are the demographic data of the patient such as weight, age and height, the vital signs such as heart rate, arterial pressure, SpO2 or EtCO2 during general anaesthesia, BMI, gestational age and parity, type of anaesthesia, doses and type of anaesthetic used, the development of adverse effects such as hypothermia or hypothension, the blood leaks, the environmental temperature on operative theatre, the temperature of fluids iv in the perioperative period, the maternal core temperature at preoperative, during induction of anaesthesia, after 5 minutes initiating anaesthesia, and then every 10 minutes until the end of the cesarean delivery and also at child birth, at the exit of operative theatre. Maternal temperature measurment will be obtained by using a skin sensor Spot On on a temporal region, the neonatal axillary temperature at 1 and5 minutes from birth using a digital thermometer, Apgar score and umbilical cord blood pH, the pain evaluation using a VAS scale ( 0-10), the maternal shivering by the Bedside Shivering Assessment scale, the maternal comfort using a verbal numerical scale ( 0 = as worst immaginable cold 50= as thermoneutral and 100= as insufferably hot), the timing of pain at induction of anaesthesia and then every 10 minutes until the operative room exit.

Interventions

DEVICEforced air warming and warmed intravenous fluids

Use of warming system (forced air)

DEVICEwarmed intravenous fluids

Use of warming system to have warmed intravenous fluids

Sponsors

University of Foggia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

all healthy parturients over eighteen years undergoing cesarean delivery

Exclusion criteria

* Fever; * Diabetes mellitus; * BMI\> 40Kg/m²; * Coaugulation disorders; * Pre-eclampsia and eclampsia; * Increased risk of intraoperative hemorrhage

Design outcomes

Primary

MeasureTime frameDescription
incidence of hypothermia (body temperature < 36°C)From the date of randomization until the end of surgery, up to four hours of surgeryto assess the incidence of maternal hypothermia during caesarean delivery

Secondary

MeasureTime frameDescription
Incidence of maternal shiveringFrom the date of randomization until the end of surgery, up to four hours of surgeryUse of the Bedside shivering scale (score 0 no shiver, score 1 mild shiver at the neck or thorax, score 2 moderate shiver at the neck, thorax and arms, score 3 severe shiver at the neck, thorax, arms and legs. Score 2 and 3 are the worse outcomes
Neonatal body temperature (T°C)From neonatal birth until five minutes after the birthwith axillary thermometer
Neonatal Apgar scoreFrom neonatal birth and until five minutes after the birthMeasurement of Apgar score
Incidence of maternal coagulative disordersFrom the date of randomization until the end of surgery, up to four hours of surgeryThromboelastography
maternal thermal comfortFrom the date of randomization until the end of surgery, up to four hours of surgeryUse of a VAS 0-100 scale (100=insufferably hot, 50=thermoneutral and 0=unimaginably cold); 50 thermoneutral is the better outcome cold, 0=thermally neutral, +50=insufferably hot

Countries

Italy

Contacts

Primary ContactAntonella Cotoia, MD
antonella.cotoia@unifg.it+393297174175
Backup ContactGilda Cinnella, MD
gilda.cinnella@unifg.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026